Endo Pulls Opioid Opana ER From The Market After FDA Request

Endo Pharmaceuticals Inc. announced that they will voluntarily be removing Opana ER from the market as per the FDA's request. Despite this move, the company still believes in Opana ER's safety and efficacy.